U 
1,830
0.00%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩19.97bn
FY2016FY2025
Net income
−₩37.39bn
FY2016FY2025
Free cash flow
−₩110.21bn
FY2016FY2025
Shareholders' equity
₩65.43bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩19.97bn | ₩18.56bn | ₩19.36bn | ₩36.44bn | ₩45.20bn | ₩59.61bn | ₩63.09bn | ₩47.98bn | ₩50.91bn | ₩38.88bn |
| Research and development | ₩7.53bn | ₩6.32bn | ₩5.54bn | ₩5.53bn | ₩4.76bn | ₩5.69bn | — | ₩2.81bn | ₩1.64bn | ₩1.21bn |
| Operating income | −₩48.31bn | −₩32.30bn | −₩19.64bn | −₩5.59bn | −₩2.22bn | ₩764.8m | ₩6.33bn | ₩8.00bn | ₩14.45bn | ₩11.51bn |
| Net income | −₩37.39bn | −₩22.74bn | −₩11.63bn | −₩12.01bn | ₩1.28bn | ₩550.7m | ₩4.92bn | ₩6.45bn | ₩10.78bn | ₩12.85bn |
| Diluted earnings per share | -1,956.00 | -1,300.14 | -735.00 | -760.77 | 81.57 | 34.98 | 315.96 | 413.42 | 673.84 | 1,005.84 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩214.29bn | ₩160.64bn | ₩100.83bn | ₩115.28bn | ₩93.69bn | ₩91.24bn | ₩82.84bn | ₩77.73bn | ₩70.11bn | ₩48.70bn |
| Cash and short-term investments | — | ₩63.23bn | ₩23.36bn | ₩44.32bn | ₩22.65bn | ₩20.04bn | ₩21.84bn | ₩21.20bn | ₩29.15bn | ₩12.75bn |
| Total liabilities | ₩148.84bn | ₩86.11bn | ₩83.61bn | ₩68.02bn | ₩33.05bn | ₩32.98bn | ₩20.96bn | ₩18.19bn | ₩14.94bn | ₩30.31bn |
| Debt | ₩22.31bn | ₩33.91bn | ₩77.42bn | ₩64.75bn | ₩27.87bn | ₩25.09bn | ₩15.64bn | ₩12.25bn | ₩9.99bn | ₩26.79bn |
| Shareholders' equity | ₩65.43bn | ₩74.53bn | ₩17.19bn | ₩47.26bn | ₩60.64bn | ₩58.26bn | ₩61.88bn | ₩59.55bn | ₩55.17bn | ₩18.39bn |
| Shares outstanding | 19m | 17m | 16m | 16m | 16m | 16m | 16m | 16m | 16m | 13m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩35.23bn | −₩31.31bn | −₩8.36bn | ₩3.15bn | ₩5.76bn | ₩4.09bn | ₩12.62bn | ₩9.65bn | ₩7.07bn | ₩14.01bn |
| Capital spending | −₩74.97bn | −₩16.10bn | −₩9.84bn | −₩5.18bn | −₩4.40bn | −₩12.29bn | −₩12.20bn | −₩11.74bn | −₩4.71bn | −₩1.31bn |
| Free cash flow | −₩110.21bn | −₩47.41bn | −₩18.21bn | −₩2.02bn | ₩1.36bn | −₩8.20bn | ₩423.2m | −₩2.09bn | ₩2.36bn | ₩12.70bn |
| Dividends paid | — | −₩634,500 | — | −₩789.1m | −₩1.57bn | −₩1.56bn | −₩1.56bn | −₩1.01bn | −₩1.01bn | −₩1.01bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩5.49bn | ₩4.77bn | ₩5.12bn | ₩4.62bn | ₩5.52bn | ₩4.71bn | ₩4.42bn | ₩4.65bn |
| Operating income | ₩19.64bn | −₩11.98bn | ₩4.14bn | −₩14.16bn | −₩9.61bn | −₩9.69bn | −₩13.04bn | −₩7.09bn |
| Net income | ₩13.89bn | −₩15.25bn | −₩1.05bn | −₩15.94bn | −₩9.40bn | −₩11.01bn | −₩11.78bn | −₩9.38bn |
| Diluted earnings per share | 709.50 | -778.74 | -53.60 | -833.73 | -508.65 | -629.38 | -673.79 | -592.86 |
| Cash from operations | −₩9.81bn | −₩9.62bn | −₩6.97bn | −₩11.36bn | −₩9.01bn | −₩7.89bn | −₩31.31bn | −₩22.80bn |
| Capital spending | −₩4.77bn | −₩28.45bn | −₩24.75bn | −₩17.23bn | −₩15.04bn | −₩17.95bn | −₩16.10bn | −₩8.95bn |
| Free cash flow | −₩14.57bn | −₩38.07bn | −₩31.73bn | −₩28.59bn | −₩24.05bn | −₩25.84bn | −₩47.41bn | −₩31.75bn |
| Total assets | ₩212.58bn | ₩230.60bn | ₩214.29bn | ₩164.97bn | ₩148.66bn | ₩158.46bn | ₩160.64bn | ₩169.27bn |
| Cash and short-term investments | — | — | — | — | — | ₩36.94bn | ₩63.23bn | ₩76.81bn |
| Debt | ₩45.69bn | ₩44.85bn | ₩22.31bn | ₩12.45bn | ₩146.3m | ₩14.67bn | ₩11.18bn | ₩11.59bn |
| Shareholders' equity | ₩72.13bn | ₩56.40bn | ₩65.43bn | ₩50.72bn | ₩47.09bn | ₩63.41bn | ₩74.53bn | ₩5.79bn |
Financial ratios
Data as of 1 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | |
|---|---|---|---|---|---|---|---|
| Operating margin | -241.9% | -174.0% | -101.4% | -15.3% | -4.9% | 1.3% | — |
| Net margin | -187.2% | -122.5% | -60.1% | -33.0% | 2.8% | 0.9% | — |
| Return on equity | -57.1% | -30.5% | -67.7% | -25.4% | 2.1% | 0.9% | — |
| Return on assets | -17.4% | -14.2% | -11.5% | -10.4% | 1.4% | 0.6% | — |
| Free cash flow yield | — | — | — | — | — | — | 47.1% |
| Revenue growth | 7.6% | -4.1% | -46.9% | -19.4% | -24.2% | -5.5% | — |
| Earnings growth | 64.4% | 95.5% | -3.2% | -1035.5% | 133.2% | -88.8% | — |
| Current ratio | 0.55x | 1.55x | 0.55x | 3.05x | 1.34x | 1.34x | — |
| Debt to equity | 0.34x | 0.15x | 0.83x | 1.13x | 0.41x | 0.38x | — |
| Equity ratio | 30.5% | 46.4% | 17.0% | 41.0% | 64.7% | 63.9% | — |
| Interest coverage | -6.18x | -7.47x | -12.10x | -7.71x | -4.48x | 1.58x | — |
| R&D as a share of sales | 37.7% | 34.1% | 28.6% | 15.2% | 10.5% | 9.5% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -18.2% | -19.6% | 2.7% |
| Operating income | 105.2% | — | 20.8% |
| Net income | 46.0% | — | 18.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -209.2% | -112.2% | -53.9% | -17.9% |
| Net margin | -156.0% | -88.8% | -41.1% | -13.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -10.2 | -20.1 | -49.0 | -33.9 | 196.2 | — | 58.5 | 13.7 | 9.5 |
| Price to sales | 19.1 | 24.6 | 29.4 | 11.2 | 5.6 | 4.8 | 4.6 | 1.9 | 2.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 29 Dec 2021.
| FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|
| Paid in the year | 50.00 | 100.00 | 100.00 | 163.333 |
- 3-for-1 split · 8 Nov 2018
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.